168 related articles for article (PubMed ID: 35457224)
1. New Cases of Hypochromic Microcytic Anemia Due to Mutations in the
Romero-Cortadellas L; Hernández G; Ferrer-Cortès X; Zalba-Jadraque L; Fuster JL; Bermúdez-Cortés M; Galera-Miñarro AM; Pérez-Montero S; Tornador C; Sánchez M
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457224
[TBL] [Abstract][Full Text] [Related]
2. A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload.
Bardou-Jacquet E; Island ML; Jouanolle AM; Détivaud L; Fatih N; Ropert M; Brissot E; Mosser A; Maisonneuve H; Brissot P; Loréal O
Blood Cells Mol Dis; 2011 Dec; 47(4):243-8. PubMed ID: 21871825
[TBL] [Abstract][Full Text] [Related]
3. A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload.
Lam-Yuk-Tseung S; Camaschella C; Iolascon A; Gros P
Blood Cells Mol Dis; 2006; 36(3):347-54. PubMed ID: 16584902
[TBL] [Abstract][Full Text] [Related]
4. Not all DMT1 mutations lead to iron overload.
Blanco E; Kannengiesser C; Grandchamp B; Tasso M; Beaumont C
Blood Cells Mol Dis; 2009; 43(2):199-201. PubMed ID: 19553145
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the E399D DMT1/NRAMP2/SLC11A2 protein produced by an exon 12 mutation in a patient with microcytic anemia and iron overload.
Lam-Yuk-Tseung S; Mathieu M; Gros P
Blood Cells Mol Dis; 2005; 35(2):212-6. PubMed ID: 16023393
[TBL] [Abstract][Full Text] [Related]
6. The homozygous mutation G75R in the human SLC11A2 gene leads to microcytic anaemia and iron overload.
Barrios M; Moreno-Carralero MI; Cuadrado-Grande N; Baro M; Vivanco JL; Morán-Jiménez MJ
Br J Haematol; 2012 May; 157(4):514-6. PubMed ID: 22313374
[No Abstract] [Full Text] [Related]
7. Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake.
Priwitzerova M; Nie G; Sheftel AD; Pospisilova D; Divoky V; Ponka P
Blood; 2005 Dec; 106(12):3985-7. PubMed ID: 16091455
[TBL] [Abstract][Full Text] [Related]
8. H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.
Shawki A; Knight PB; Maliken BD; Niespodzany EJ; Mackenzie B
Curr Top Membr; 2012; 70():169-214. PubMed ID: 23177986
[TBL] [Abstract][Full Text] [Related]
9. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).
Iolascon A; d'Apolito M; Servedio V; Cimmino F; Piga A; Camaschella C
Blood; 2006 Jan; 107(1):349-54. PubMed ID: 16160008
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.
Mims MP; Guan Y; Pospisilova D; Priwitzerova M; Indrak K; Ponka P; Divoky V; Prchal JT
Blood; 2005 Feb; 105(3):1337-42. PubMed ID: 15459009
[TBL] [Abstract][Full Text] [Related]
11. Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload.
Beaumont C; Delaunay J; Hetet G; Grandchamp B; de Montalembert M; Tchernia G
Blood; 2006 May; 107(10):4168-70. PubMed ID: 16439678
[TBL] [Abstract][Full Text] [Related]
12. Intestinal DMT1 is critical for iron absorption in the mouse but is not required for the absorption of copper or manganese.
Shawki A; Anthony SR; Nose Y; Engevik MA; Niespodzany EJ; Barrientos T; Öhrvik H; Worrell RT; Thiele DJ; Mackenzie B
Am J Physiol Gastrointest Liver Physiol; 2015 Oct; 309(8):G635-47. PubMed ID: 26294671
[TBL] [Abstract][Full Text] [Related]
13. Carboxyl-terminus determinants of the iron transporter DMT1/SLC11A2 isoform II (-IRE/1B) mediate internalization from the plasma membrane into recycling endosomes.
Lam-Yuk-Tseung S; Touret N; Grinstein S; Gros P
Biochemistry; 2005 Sep; 44(36):12149-59. PubMed ID: 16142913
[TBL] [Abstract][Full Text] [Related]
14. Natural history of recessive inheritance of DMT1 mutations.
Iolascon A; Camaschella C; Pospisilova D; Piscopo C; Tchernia G; Beaumont C
J Pediatr; 2008 Jan; 152(1):136-9. PubMed ID: 18154916
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the gene encoding DMT1: clinical presentation and treatment.
Iolascon A; De Falco L
Semin Hematol; 2009 Oct; 46(4):358-70. PubMed ID: 19786204
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts.
Horvathova M; Kapralova K; Zidova Z; Dolezal D; Pospisilova D; Divoky V
Haematologica; 2012 Oct; 97(10):1480-8. PubMed ID: 22580996
[TBL] [Abstract][Full Text] [Related]
17. Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload.
Casale M; Borriello A; Scianguetta S; Roberti D; Caiazza M; Bencivenga D; Tartaglione I; Ladogana S; Maruzzi M; Della Ragione F; Perrotta S
Am J Hematol; 2018 Mar; 93(3):E58-E60. PubMed ID: 29178181
[No Abstract] [Full Text] [Related]
18. Divalent metal transporter 1.
Mims MP; Prchal JT
Hematology; 2005 Aug; 10(4):339-45. PubMed ID: 16085548
[TBL] [Abstract][Full Text] [Related]
19. Discovery and characterization of a novel non-competitive inhibitor of the divalent metal transporter DMT1/SLC11A2.
Montalbetti N; Simonin A; Simonin C; Awale M; Reymond JL; Hediger MA
Biochem Pharmacol; 2015 Aug; 96(3):216-24. PubMed ID: 26047847
[TBL] [Abstract][Full Text] [Related]
20. Iron handling and gene expression of the divalent metal transporter, DMT1, in the kidney of the anemic Belgrade (b) rat.
Ferguson CJ; Wareing M; Delannoy M; Fenton R; McLarnon SJ; Ashton N; Cox AG; McMahon RF; Garrick LM; Green R; Smith CP; Riccardi D
Kidney Int; 2003 Nov; 64(5):1755-64. PubMed ID: 14531808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
